Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Ambulatory Encounters Low for US Patients with HS

Dermatology (Karger); ePub 2017 Sep 28; Garg, et al

Utilization of the ambulatory dermatology encounter among patients with hidradenitis suppurativa (HS) is low in the US, according to a recent study. Furthermore, factors other than insurance status influenced this level of utilization. Researchers conducted a retrospective cohort analysis in an adult population sample of 42,030 patients with HS with either private or public health insurance who were identified by a validated scheme using SNOMED-CT terminology. The primary outcome was a dichotomous variable defined as having at least 1 ambulatory encounter with a dermatologist over a 3-year period. They found:

  • Overall, 21.8% of the HS patients had at least 1 ambulatory encounter with a dermatologist.
  • This proportion did not significantly vary between patients with private insurance (22%), Medicaid (21.6%), and Medicare (21.7%).


Garg A, Lavian J, Strunk A. Low utilization of the dermatology ambulatory encounter among patients with hidradenitis suppurativa: A population-based retrospective cohort analysis in the USA. [Published online ahead of print September 28, 2017]. Dermatology (Karger). doi:10.1159/000480379.